UBS Group’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,010
| Closed | -$404 | – | 10054 |
|
2022
Q4 | $404 | Buy |
+1,010
| New | +$404 | ﹤0.01% | 9004 |
|
2022
Q3 | – | Sell |
-2,488
| Closed | -$3K | – | 10222 |
|
2022
Q2 | $3K | Buy |
+2,488
| New | +$3K | ﹤0.01% | 8416 |
|
2021
Q4 | – | Sell |
-431
| Closed | -$5K | – | 9722 |
|
2021
Q3 | $5K | Sell |
431
-5,078
| -92% | -$58.9K | ﹤0.01% | 7440 |
|
2021
Q2 | $56K | Buy |
5,509
+4,342
| +372% | +$44.1K | ﹤0.01% | 5275 |
|
2021
Q1 | $13K | Buy |
1,167
+1,074
| +1,155% | +$12K | ﹤0.01% | 6738 |
|
2020
Q4 | $1K | Sell |
93
-324
| -78% | -$3.48K | ﹤0.01% | 7256 |
|
2020
Q3 | $5K | Buy |
+417
| New | +$5K | ﹤0.01% | 6476 |
|